Practice Updates: Carrier Screening for Genetic Conditions, Carrier Screening in the Age of Genomic Medicine

Stay up to date with ACOG's authoritative clinical guidance and helpful patient education materials. The following provides Practice Updates for February and March 2017.


TOPIC SPOTLIGHT

Featured Committee Opinion 691: Carrier Screening for Genetic Conditions

An ACOG Committee Opinion describes carrier screening as genetic testing that is performed on an individual who does not have any overt phenotype for a genetic disorder but may have one variant allele within a gene(s) associated with a diagnosis. Carrier screening and counseling should ideally be performed before pregnancy in order for couples to understand their reproductive risk and consider the most complete range of reproductive options. ACOG recommends that genetic carrier screening be provided to every pregnant woman, and that, after counseling, a patient may decline any or all screening. Genetic counseling should be offered if one or both partners are found to be carriers of a genetic condition.  

Committee Opinion 691 Carrier Screening for Genetic Conditions is available in the March 2017 issue of Obstetrics and Gynecology.


Featured Committee Opinion 690: Carrier Screening in the Age of Genomic Medicine

The goal of genetic screening is to provide individuals with meaningful information that they can use to guide pregnancy planning based on their personal values. The Committee Opinion notes that ethnic-specific, panethnic, and expanded carrier screening are acceptable strategies for prepregnancy and prenatal carrier screening. ACOG recommends that patients who are pregnant or considering pregnancy be offered carrier screening for cystic fibrosis, spinal muscular atrophy, and a complete blood count and screening for thalassemias and hemoglobinopathies. Prenatal carrier screening does not replace newborn screening, nor does newborn screening diminish the potential benefit of prenatal carrier screening.

Committee Opinion 690 Carrier Screening in the Age of Genomic Medicine is available in the March 2017 issue of Obstetrics and Gynecology


Zika Information

ACOG’s Zika webpage

ACOG Zika Toolkit, including patient education video, infographic, and assessment web tool endorsed by CDC

CDC’s Pregnancy and Zika Testing Clinical Algorithm

CDC Zika Virus Website

State Health Department Contact list for ob-gyns (members only) for questions on CDC’s Zika Registry

State Health Department Contact list for ob-gyns (members only) for questions on testing

CDC Zika Pregnancy Hotline for Health Care Providers: Ob-gyns can contact the CDC Zika Pregnancy Hotline at 770-488-7100, or email ZikaPregnancy@cdc.gov for any concerns related to clinical management or the US Zika Pregnancy Registry

Office of Population Affairs' Zika Toolkit

ll

ll

LIST OF NEW PRACTICE PUBLICATIONS, FEBRUARY/MARCH 2017

New Committee Opinions

See all Committee Opinions

                                                                                                                                  

New Practice Bulletins (members only) 

  • No new Practice Bulletins were issued in February/March 2017

See all Practice Bulletins


New Title: Clinical Updates in Women's Health Care (members only)

See all Clinical Updates Titles


New Patient Education Pamphlets (members only)

  • 179 Carrier Screening (Coming later in March 2017)
  • 171 Cystic Fibrosis (Coming later in March 2017)
  • 127 Vulvodynia (Coming later in March 2017)
  • 075 Ovarian Cysts (Coming later in March 2017)

See all Patient Education Pamphlets


Frequently Asked Questions (FAQs) for Patients

  • 095 Abnormal Uterine Bleeding (Coming later in March 2017)
  • 026 Benign Breast Problems (Coming later in March 2017)

See all Frequently Asked Questions

 

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998